Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Bought by the CFO, one of the two people with the fullest view of the company.
- Their first purchase here in our data, after 1 sale.
- Similar past buys beat the S&P 500 52% of the time (110 cases), above the 46% for all buys.
Reasons for caution
- None found in the data.
What happened after this filing
Insider Twins: past buys with the same traits
2 insiders buying · incl. CEO or CFO · $250K–$1M · stock down 20%+ in 3 months
BCAB Jun 23, 2022 +189.1% vs S&PFCNCA Mar 13, 2023 +106.4% vs S&PPFSI Mar 20, 2020 +98.6% vs S&PMYO May 15, 2025 -77.0% vs S&PMITT Mar 12, 2020 -68.1% vs S&PANDE Mar 18, 2020 -55.5% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Alan Wayne Ellingson (CFO) bought $350K of DKNG at about $18.51 on Nov 9, 2026, reported to the SEC on Nov 9, 2026. Buys like this beat the S&P 500 52% of the time since 2020, against 46% for all insider buys. We found 4 points that make it worth a closer look and 0 reasons for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the DKNG alerts below.
Get this week's insider report
The week's biggest insider buys, every new cluster buy and the stocks to watch, in one printable PDF. Plus the free Monday email.
Check your inbox to confirm, so you get next week's report too.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.